Melissa Andel Previews Her Upcoming Session on Drug Pricing Reform at AMCP 2022

Melissa Andel, principal at CommonHealth Solutions, previewed her session on policy making and pricing reform at the upcoming Academy of Managed Care Pharmacy's annual meeting.

Transcript

What will you be talking about during your session at AMCP 2022?

So, my session is just going to be an update on what's going on here in [Washington,] DC, mainly with regard to Congress, as well as what the Biden administration has been working on with respect to drug price reform. So, not just reconciliation, but also some of the administrative rules that HHS has, which also includes CMS and HRSA [Health Resources and Services Administration], and some of the actions that the Biden administration has been working on and what that means for patients and payers and manufacturers.

What other presentations are you looking forward to checking out at AMCP 2022?

Oh, yeah, so I've got a couple. I was filling out my agenda the other day. But yeah, there's a couple on digital therapeutics that I'm looking forward to and also a few on value-based purchasing contracts and 340B and the Medicaid pharmacy benefit that I'm looking forward to attending. So, the sessions that are on some of the newer trends that are facing payers and the industry are always interesting to me.